Reneo Pharmaceuticals

Reneo Pharmaceuticals, headquartered in California, USA, is a clinical-stage pharmaceutical company focused on developing treatments for patients with inherited mitochondrial diseases. The company's current clinical research programs primarily target several inherited metabolic disorders, including primary mitochondrial myopathy and fatty acid oxidation disorders.